Patent details

EP2329259 Title: MARKERS AND METHODS FOR ASSESSING AND TREATING ULCERATIVE COLITIS AND RELATED DISORDERS USING A 20 GENE PANEL

Basic Information

Publication number:
EP2329259
PCT Application Number:
PCT/US/2009/055323
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP098106438
PCT Publication Number:
WO/2010/025340
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MARKERS AND METHODS FOR ASSESSING AND TREATING ULCERATIVE COLITIS AND RELATED DISORDERS USING A 20 GENE PANEL
French Title of Invention:
MARQUEURS ET PROCÉDÉS POUR ÉVALUER ET POUR TRAITER UNE RECTO-COLITE HÉMORRAGIQUE ET DES TROUBLES ASSOCIÉS À L'AIDE D'UN ENSEMBLE DE 20 GÈNES
German Title of Invention:
MARKER UND VERFAHREN ZUR BEURTEILUNG UND BEHANDLUNG VON COLITIS ULCEROSA SOWIE VERWANDTEN ERKRANKUNGEN MIT EINEM 20-GEN-PANEL
SPC Number:

Dates

Filing date:
28/08/2009
Grant date:
20/04/2016
EP Publication Date:
20/04/2016
PCT Publication Date:
04/03/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/06/2011
EP B1 Publication Date:
20/04/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/08/2016
Expiration date:
28/08/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/08/2009
 
 

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)

Inventor

1

Name:
BARIBAUD Frederic
Address:
United States (US)

2

Name:
LI Xilin
Address:
United States (US)

Priority

Priority Number:
92966 P
Priority Date:
29/08/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
G01N 33/48;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages